ES2055685T3 - Procedimiento para la obtencion de un medicamento que contiene ibuprofen. - Google Patents

Procedimiento para la obtencion de un medicamento que contiene ibuprofen.

Info

Publication number
ES2055685T3
ES2055685T3 ES86115843T ES86115843T ES2055685T3 ES 2055685 T3 ES2055685 T3 ES 2055685T3 ES 86115843 T ES86115843 T ES 86115843T ES 86115843 T ES86115843 T ES 86115843T ES 2055685 T3 ES2055685 T3 ES 2055685T3
Authority
ES
Spain
Prior art keywords
procedure
obtaining
product containing
medicinal product
containing ibuprofen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES86115843T
Other languages
English (en)
Inventor
Dieter Pd Dr Dr Loew
Otto Dr Schuster
J Dr Lukas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PUETTER MEDICE CHEM PHARM
Original Assignee
PUETTER MEDICE CHEM PHARM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39642881&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2055685(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by PUETTER MEDICE CHEM PHARM filed Critical PUETTER MEDICE CHEM PHARM
Application granted granted Critical
Publication of ES2055685T3 publication Critical patent/ES2055685T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE MUESTRA UN MEDICAMENTO QUE CONTIENE IBUPROFEN. ESTE IBUPROFEN SOLO SE ENCUENTRA EN LA FORMULA (S)-(+). (S)-(+) -IBUPROFEN ES MAS DEL DOBLE DE ACTIVO QUE RACEMAT EL CUAL HA SIDO UTILIZADO HASTA AHORA EN LA TERAPEUTICA REUMATICA. DE ESE MODO LA CANTIDAD ACTIVADORA SE DISMINUYE Y EL TAMAÑO DE LOS COMPRIMIDOS Y GRAGEAS SE REDUCE.
ES86115843T 1986-11-14 1986-11-14 Procedimiento para la obtencion de un medicamento que contiene ibuprofen. Expired - Lifetime ES2055685T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP86115843A EP0267321B1 (de) 1986-11-14 1986-11-14 Ibuprofen enthaltendes Arzneimittel
DE3639038A DE3639038C2 (de) 1986-11-14 1986-11-14 Verwendung von S-(+)-Ibuprofen zur schnellen Behandlung humaner Schmerzen

Publications (1)

Publication Number Publication Date
ES2055685T3 true ES2055685T3 (es) 1994-09-01

Family

ID=39642881

Family Applications (1)

Application Number Title Priority Date Filing Date
ES86115843T Expired - Lifetime ES2055685T3 (es) 1986-11-14 1986-11-14 Procedimiento para la obtencion de un medicamento que contiene ibuprofen.

Country Status (9)

Country Link
US (1) US4877620A (es)
EP (1) EP0267321B1 (es)
JP (1) JPS63146815A (es)
AT (1) ATE50493T1 (es)
DE (2) DE3639038C2 (es)
ES (1) ES2055685T3 (es)
GR (1) GR3000292T3 (es)
IL (1) IL84425A (es)
ZA (1) ZA878400B (es)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5519057A (en) * 1986-11-14 1996-05-21 Johnson & Johnson--Merck Pharmaceuticals Co. Ibuprofen-containing medicament
US4980375A (en) * 1987-07-10 1990-12-25 Sterling Drug Inc. Onset-hastened/enhanced antipyretic response
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia
US5028625A (en) * 1989-06-20 1991-07-02 American Home Products Corporation Acid addition salt of ibuprofen and meglumine
DE3922441A1 (de) * 1989-07-07 1991-01-17 Pharmatrans Sanaq Ag Ibuprofen- und s-(+)-ibuprofen-zubereitungen und verfahren zu ihrer herstellung
US5200558A (en) * 1989-10-17 1993-04-06 Merck & Co., Inc. S(+)-ibuprofen-L-amino acid and S(+)-ibuprofen-D-amino acid as onset-hastened enhanced analgesics
EP0424028B1 (en) * 1989-10-17 1995-09-27 Merck & Co. Inc. S(+)-ibuprofen-L-amino acid and S(+)-ibuprofen-D-amino acid as onset hastened enhanced analgesics
US5093133A (en) * 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
WO1992005786A1 (en) * 1990-09-28 1992-04-16 Merck & Co., Inc. Ibuprofen-diuretic combinations
EP0550668A4 (en) * 1990-09-28 1993-10-13 Merck & Co. Inc. Ibuprofen-antihistamine combinations
HUT59656A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing s/+/-phenyl-alkanoic acids and alpha-amino-acids containing complexes and pharmaceutical compositions containing them as active components
HUT59692A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing complexes containing s/+/-phenyl-alkanoic acids and aminosugars
DE4038314A1 (de) * 1990-11-30 1992-06-04 Puetter Medice Chem Pharm Komplexe des aktiven enantiomers des ibuprofens mit cyclodextrin
US5164398A (en) * 1991-04-01 1992-11-17 Merck & Co., Inc. Ibuprofen-antitussive combinations
CA2107331A1 (en) * 1991-04-01 1992-10-02 Robert T. Sims Ibuprofen-decongestant combinations
US5145674A (en) * 1991-04-30 1992-09-08 The Dow Chemical Company Biologically-active compounds comprising a biologically-active anionic portion and a water-insoluble, inorganic cationic portion
ES2148175T3 (es) 1991-05-13 2000-10-16 Boots Co Plc Composicion farmaceutica que contiene una sal de ibuprofeno.
DE4140184C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140183C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140172C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Ibuprofen enthaltendes Arzneimittel
DE4140185C2 (de) * 1991-12-05 1996-02-01 Alfatec Pharma Gmbh Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung
DE4140179C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Ibuprofen enthaltendes Arzneimittel
US5466680A (en) * 1992-03-26 1995-11-14 Cytologics, Inc. Method and compositions for enhancing white blood cell functioning on a mucosal or cutaneous surface
DE4216756C2 (de) * 1992-05-21 1994-08-25 Pharmatrans Sanaq Ag 2-Arylpropionsäure-Zubereitungen und Verfahren zu ihrer Herstellung
US5288507A (en) * 1992-07-29 1994-02-22 Merck & Co., Inc. Ibuprofen antacid combinations
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations
DE59209706D1 (de) * 1992-12-01 1999-07-08 Spirig Ag S(+)-Ibuprofen enthaltende Arzneimittel
DE4319438C1 (de) * 1993-06-11 1994-06-01 Gerd Dr Dr Geislinger Arzneimittel auf der Grundlage von Ketoprofen zur Bekämpfung von Schmerzen und/oder Entzündungen und/oder Fieber an Menschen und Tieren
IT1264856B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica ad attivita' analgesica
IT1264857B1 (it) 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica liquida per uso orale contenente acido 2-(4-isobutilfenil) propionico
AT401871B (de) * 1994-01-28 1996-12-27 Gebro Broschek Gmbh Verfahren zur herstellung von s(+)-ibuprofen- partikeln mit verbesserten fliesseigenschaften und deren verwendung zur arzneimittelherstellung
IT1270239B (it) * 1994-06-17 1997-04-29 Zambon Spa Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
IT1274879B (it) * 1994-08-03 1997-07-25 Saitec Srl Apparecchio e metodo per preparare forme farmaceutiche solide a rilascio controllato del principio attivo.
CA2178686A1 (en) * 1995-06-13 1996-12-14 Leslie G. Humber Oral formulations of s(+)-etodolac
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
IT1277741B1 (it) * 1995-12-28 1997-11-12 Dompe Spa Composizioni farmaceutiche parenterali contenenti sali di alchilammonio di acidi 2-arilpropionici
DE19606151C2 (de) * 1996-02-20 1999-05-12 Losan Pharma Gmbh Ibuprofen-Brausezubereitung sowie Verfahren zur Herstellung derselben
US5648358A (en) * 1996-03-05 1997-07-15 Mitra; Sekhar Compositions and methods for treating respiratory disorders
WO1997047572A1 (en) * 1996-06-10 1997-12-18 Albemarle Corporation Racemization process for optically active carboxylic acids or salts or esters thereof
DE19733505A1 (de) 1997-08-01 1999-02-04 Knoll Ag Schnell wirksames Analgeticum
US5874614A (en) * 1997-12-11 1999-02-23 Albemarle Corporation Sodium (S)-2-(6-methoxy-2-naphthyl)propionate monohydrate
US5859292A (en) * 1997-12-11 1999-01-12 Albemarle Corporation Preparation of high purity sodium (S)-2(6-methoxy-2-naphthyl)propionate
GB0113839D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
US6551615B1 (en) 2001-10-18 2003-04-22 M/S. Strides Arcolab Limited Dexibuprofen-containing soft gelatin capsules and process for preparing the same
WO2004050025A2 (en) * 2002-11-29 2004-06-17 Forest Laboratories, Inc. Combination of ibuprofen and oxycodone for acute pain relief
KR20050005883A (ko) * 2003-07-07 2005-01-15 안국약품 주식회사 덱시부프로펜을 유효성분으로 한 해열제
US7662803B2 (en) * 2004-09-17 2010-02-16 Gluconova, LLC Method for treating warm-blooded vertebrates with halide-free glucosamine-acidic drug complexes
US20070259043A1 (en) * 2004-09-17 2007-11-08 Jame Fine Chemicals, Inc. Halide-free glucosamine-therapeutic drug salt compositions
US7662802B2 (en) * 2004-09-17 2010-02-16 Gluconova, LLC Halide-free glucosamine-acidic drug complexes
US20060068009A1 (en) * 2004-09-30 2006-03-30 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US20070077297A1 (en) 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US7749537B2 (en) * 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
JP5985985B2 (ja) * 2009-08-03 2016-09-06 エミスフィアー テクノロジーズ インコーポレイテッドＥｍｉｓｐｈｅｒｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ，Ｉｎｃ． 胃腸への影響が減少した即効型ナプロキセン組成物
WO2012151427A1 (en) 2011-05-03 2012-11-08 Aponia Laboratories, Inc. Transdermal compositions of ibuprofen and methods of use thereof
KR101745116B1 (ko) * 2015-07-27 2017-06-08 현대자동차주식회사 사출 성형용 열가소성 폴리우레탄 조성물 및 그 제조방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
US4713249A (en) * 1981-11-12 1987-12-15 Schroeder Ulf Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
DE3301328A1 (de) * 1982-02-01 1983-08-11 The Upjohn Co., 49001 Kalamazoo, Mich. Arzneimittel zur einleitenden bekaempfung von akuter oder chronischer, myelogener leukaemie
DE3205504C2 (de) * 1982-02-16 1983-12-01 Dolorgiet Gmbh & Co Kg, 5300 Bonn Äußerlich anwendbares, Ibuprofen enthaltendes Arzneimittel
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
DE3437599A1 (de) * 1984-10-13 1986-04-17 Dolorgiet GmbH & Co KG, 5205 St Augustin Ibuprofen enthaltende weichgelatinekapseln und verfahren zu ihrer herstellung
JPS61210049A (ja) * 1984-11-21 1986-09-18 Daicel Chem Ind Ltd 光学活性なα↓−芳香族基置換アルカンカルボン酸類の製造方法
US4571400A (en) * 1984-12-18 1986-02-18 Belleview Pharmaceutical, Inc. Dihydrocodeine/ibuprofen pharmaceutical compositions and method
US4569937A (en) * 1985-02-11 1986-02-11 E. I. Du Pont De Nemours And Company Analgesic mixture of oxycodone and ibuprofen
US4695591A (en) * 1985-03-29 1987-09-22 Schering Corporation Controlled release dosage forms comprising hydroxypropylmethylcellulose
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
US4684666A (en) * 1986-08-19 1987-08-04 Haas Pharmaceuticals, Inc. Stabilized liquid analgesic compositions
GB8623557D0 (en) * 1986-10-01 1986-11-05 Boots Co Plc Therapeutic agents

Also Published As

Publication number Publication date
ZA878400B (en) 1988-05-03
IL84425A (en) 1993-07-08
EP0267321B1 (de) 1990-02-28
EP0267321A1 (de) 1988-05-18
ATE50493T1 (de) 1990-03-15
GR3000292T3 (en) 1991-03-15
IL84425A0 (en) 1988-04-29
DE3669103D1 (de) 1990-04-05
DE3639038C2 (de) 1997-02-06
JPS63146815A (ja) 1988-06-18
DE3639038A1 (de) 1988-07-28
US4877620A (en) 1989-10-31

Similar Documents

Publication Publication Date Title
ES2055685T3 (es) Procedimiento para la obtencion de un medicamento que contiene ibuprofen.
ES2000428T3 (es) Procedimiento para producir un medicamento para el tratamiento de la enfermedad de alzheimer, que contiene galantamina, y dispositivo medico correspondiente.
DE3853191D1 (de) Arzneimittelträger.
AR042262A2 (es) Uso de 8,9-dihidroestrona para la preparacion de un medicamento para el tratamiento de aterosclerosis
ES511433A0 (es) "procedimiento de preparacion de productos utiles particularmente en medicamentos utilizables para el tratamiento de melanomas".
NO874329D0 (no) Hylser for "sommerfugl"-naaler.
AU3057784A (en) 7, 10, 13, 16 docosatetraenoic acid composition
FR2599961B1 (fr) Piece a main medicale a laser.
GR3020902T3 (en) Use of 15-keto-prostaglandin compound for improvement of encephalic function
MY106263A (en) Method for the treatment or prevention of intrinsically aged skin with retinoids
ES514766A0 (es) Procedimiento para la produccion de un alcaloide peptidico ciclico del 9'-tia-cornezuelo de centeno.
DE3880667D1 (de) Ampulle zur gesteuerten verabreichung eines heilmittels.
MX9201218A (es) Procedimiento para la preparacion de 2,2-dicloro-1,1,1-trifluoro etano, 2-cloro-1,1,1,2- tetra fluoro etano y penta fluoro etano.
EP0424156A3 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
SE8900875L (sv) Osteoporosbehandling
DE3766885D1 (en) Chlorpheniramine therapie.
IT8720350A0 (it) Procedimento per la fabbricazione tramite iniezione di contenitori, in particolare contenitori aventi incorporata un'etichetta.
ES2059882T3 (es) Preparacion de la sustancia fr 115224 para administracion parenteral.
FR2518881B1 (fr) Medicaments a base de 26,23-lactones de la 25-hydroxyvitamine d3, utiles notamment pour agir sur la concentration en calcium du serum
DE3686534D1 (de) Verwendung eines retinoids zur herstellung eines zytostatischen arzneimittels.
IT1224250B (it) Associzione del depiprazolo con la morfina
ES2044144T3 (es) Nuevo procedimiento para la produccion de 4,6-dimetil-7-hidroxinonan-3-ona.
IT8720060A0 (it) Perfluoro 2,3,4-trimetilpentano eprocedimento per la sua preparazione.
ES2050655T3 (es) Aguja quirurgica oscura.
ATE46443T1 (de) Arzneimittel zur behandlung von herpes.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 267321

Country of ref document: ES